Search Results
Search results for "Ping Chi"
Results found for "Ping Chi"
- Dr. Thomas P. Sakmar | Dr. GPCR Ecosystem
While a chemistry undergraduate student at the University of Chicago, he attended a NATO Advanced Study Recently, Tom’s lab discovered, along with Yu Chen and Ping Chi , that a mutant of CYSLTR2 is a driver
- Dr. Josephine (Pina) Cardarelli | Dr. GPCR Ecosystem
Josephine (Pina) Cardarelli About Dr. Josephine (Pina) Cardarelli Dr. Pina Cardarelli, CSO for GPCR Therapeutics Inc., based in South Korea, has recently been named President Josephine (Pina) Cardarelli on the web LinkedIn Company Website Dr.
- Dr. Nicholas Holliday | Dr. GPCR Ecosystem
Holliday After an undergraduate degree at the University of Cambridge, Nick carried out his Ph.D. at King Since 2019, Nick has combined his university role with the leadership of Excellerate Bioscience as Chief
- Privacy Policy | Dr. GPCR Ecosystem
Advertising Ecosystem.DrGPCR.com has implemented online advertising using Google AdWords, Yahoo, Bing It means that third-party vendors, such as Google, Yahoo, Bing, and/or Facebook, display our ads on sites
- Hacking GPCRs: Tools, Tech & Drug Discovery with Tom Sakmar & Ilana Kotliar | Dr. GPCR Ecosystem
.” – Tom Sakmar The success of this project hinged on international collaboration and a multidisciplinary He and his artist/designer wife, Karina Åberg, have three teenage children.
- Dr. Aylin Hanyaloglu | Dr. GPCR Ecosystem
She received her BSc in Human Biology from King’s College London in 1997, and while her Ph.D. commenced
- Re-cap of Endocrine Metabolic GPCR 2024 with the Organizers | Dr. GPCR Ecosystem
She received her BSc in Human Biology from King’s College London in 1997, and while her Ph.D. commenced
- Qing Fan: Inside the Architecture of Class C GPCRs | Dr. GPCR Ecosystem
Structural biologist Qing Fan describes a decade of GABA-B receptor research at Columbia - from obligate architecture means for neurological disease and drug design. << Back to podcast list Strategic Partner(s) Qing ABOUT THE GUEST Qing Fan is an associate professor of pharmacology and pathology and cell biology at Join us and learn more about Qing's work and how we powered through a technical issue during the interview Qing Fan on the web Fan Lab Dr. Fan at Columbia University Research Gate LinkedIn Pubmed Dr.
- Your GPCR Order Has Arrived! ❇ Feb 10 - 16, 2025 | Dr. GPCR Ecosystem
Cell type-dependent involvement of Gi, Gq, Gs proteins and protein kinase C Qin Wang , Wenwen Hao , Jing
- David Gloriam: Orphan Receptors, GPCRDB, and the Data Revolution in GPCR Pharmacology | Dr. GPCR Ecosystem
published audio before use. 00:00 Welcome and introduction of David Gloriam 02:23 Career origins - from childhood
- Scaling GLP 1 Receptor Tools Through Academia Industry Collaboration | Dr. GPCR Ecosystem
Maria Majellaro is the Chief Scientific Officer and co-founder of Celtarys Research , a biotech spin-off
- Annette Gilchrist: Native Cell Systems, Biased Agonism, and the Pharmacogenomics Gap | Dr. GPCR Ecosystem
University of Connecticut and went on to become a postdoctoral fellow at UIC (University of Illinois at Chicago
- Signals, pH, and Discovery : Cracking GPCR Mysteries with Dr. Ian Chronis | Dr. GPCR Ecosystem
Ian discusses how his experiences at the University of Chicago and the University of Michigan shaped
- Dr. Lukas Grätz | Dr. GPCR Ecosystem
My initial focus was on creating an automated chimeric homology modeling pipeline for GPCRs and since In my free time I like to play the guitar, sing and play board games. " Dr.
- Dr. Oliver Hartley | Dr. GPCR Ecosystem
intellectual property, and at the Mintaka Foundation for Medical Research with a role as co-founder and Chief
- Aaron Sato: Synthetic Antibody Libraries for the Hardest GPCR Targets | Dr. GPCR Ecosystem
Aaron Sato is the Chief Scientific Officer and VP of Protein Engineering at Twist Biopharma, the biologics synthetic phage display libraries that drug targets the field has long treated as intractable — GPCRs chief Aaron is currently the Chief Scientific Officer and VP of Protein Engineering.
- Dr. Claudia Stäubert | Dr. GPCR Ecosystem
Affordable Childcare and GPCR Research Discussion Yamina and Claudia discussed the importance of affordable childcare and the experiences of PhD students in the US and Europe.
- Elva Zhao: G Protein Regulation and Biased Signaling at the GLP-1 Receptor | Dr. GPCR Ecosystem
The connection runs deeper than science: Zhao's grandmother worked as a pharmacologist on diabetes in China Peter Chidiac, where her work focused on the kinetic regulation of G protein cycling by RGS proteins Her mentor, Peter Chidiac, had consistently avoided steering her toward a predetermined career path, University 06:49 First contact with G proteins - the muscarinic receptor as a tool, not a subject 09:17 From China
- Who We Are | Dr. GPCR Ecosystem
Maria Waldhoer Get in Touch Co-Founder Attila Foris Get in Touch Board Member JoAnn Trejo Get in Touch Chief
- Custom Molecules, Fluorescent Probes: When Chemists Think Like Biologists with Dr. Maria Majellaro from Celtarys | Dr. GPCR Ecosystem
Since the founding of Celtarys in 2021, she has served as the company’s Chief Scientific Officer, leading
- From Curiosity to Breakthrough: Ajay Yekkirala on GPCR Innovation | Dr. GPCR Ecosystem
Clifford Woolf at Boston Children’s Hospital and Harvard Medical School, where he deepened his understanding
- Charlotte Crauwels: Designing Hybrid GPCRs with Computational Protein Engineering | Dr. GPCR Ecosystem
Crauwels discusses her work developing computational strategies to support the design of hybrid or chimeric Crauwels’ research focuses on building computational pipelines that guide the rational design of GPCR chimeras Her research centers on developing computational pipelines that guide the design of hybrid or chimeric Scientific Themes of the Conversation Computational protein design for GPCR engineering Hybrid and chimeric and Data Challenges The challenge of collecting standardized data on chimeric GPCR experiments. 41:30
- About Dr. GPCR Ecosystem | Uniting the GPCR Community to Advance Drug Discovery
Quinn Get in touch Board Member JoAnn Trejo Get in touch Board Member Maria Waldhoer Get in touch Chief
- Tore Bengtsson: Rethinking β₂-Adrenergic Signaling in Metabolic Disease | Dr. GPCR Ecosystem
Translating receptor pharmacology into metabolic therapeutics Key Insights from the Conversation A Childhood Bengtsson recounts a formative experience when his father pushed him into icy water as a child to demonstrate Bengtsson 03:00 A childhood experiment that sparked interest in physiology 07:00 Cold exposure, sympathetic
- Fiona Marshall: Three Decades Inside GPCR Drug Discovery | Dr. GPCR Ecosystem
She co-founded Heptares Therapeutics and served as Chief Scientific Officer for twelve years, through
- Content and Conduct Policy | Dr. GPCR Ecosystem
Child Exploitation Do not upload or share content that exploits or abuses children. This includes all child sexual abuse imagery (even cartoon images or videos) and all content that presents children in a sexual manner. , which may include disabling accounts and reporting to the National Center for Missing & Exploited Children If you find any content that you think exploits children in this manner, do not share or comment on such
- Brian Arey: Discovering Signaling Bias at the FSH Receptor | Dr. GPCR Ecosystem
That argument eventually became a book, co-authored with Terry Kenakin, that Arey dedicated to his children chased the trending field 35:00 Science, family, and the years he was a single father of two young children
- Maria Waldhoer: Pharmacological Fingerprints and the Limits of Bias | Dr. GPCR Ecosystem
Maria Waldhoer is Chief Scientific Officer at InterAx Biotech AG in Switzerland. , Maria worked several years at Novo Nordisk before joining InterAx Biotech in Switzerland as their Chief
- Gáspár Pándy-Szekeres | Dr. GPCR Ecosystem
My initial focus was on creating an automated chimeric homology modeling pipeline for GPCRs and since In my free time I like to play the guitar, sing and play board games. " Gáspár Pándy-Szekeres on the
- Scott Struthers | Dr. GPCR Ecosystem
Scott Struthers, Ph.D., is our co-founder and has served as our President and Chief Executive Officer



























